Clinical trial Recruiting at 1 site Observational Ages 2 to 18

A system for diagnosing and treating children's brain diseases using advanced technology

Official title: Jiangsu Provincial Hospital of Traditional Chinese Medicine

Run by Affiliated Hospital of Nanjing University of Chinese Medicine · NCT06848959 · Data updated 2026-11-12

This study is testing a new system that uses advanced technology to help doctors diagnose and treat different brain diseases in children, like ADHD and autism, by combining ideas from both Chinese and Western medicine.

Quick facts

Study typeObservational
Ages2 Years to 18 Years
SexAll
Enrollment2000 (estimated)
SponsorAffiliated Hospital of Nanjing University of Chinese Medicine
Academic / other
Locations1 site (Nanjing)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedFebruary 28, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 27, 2025
Trial IDNCT06848959 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children diagnosed with cerebral palsy, mental retardation, Tourette's syndrome, ADHD, or autism spectrum disorders.

Probably not a fit

Patients with other major mental illnesses or organic diseases, such as schizophrenia or congenital heart disease, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop a comprehensive system that utilizes knowledge graphs and large model technology to assist in the diagnosis and treatment of various childhood brain diseases, including cerebral palsy, mental retardation, Tourette's syndrome, ADHD, and autism spectrum disorders. The approach combines elements of both Chinese and Western medicine to create a prevention and popularization system, as well as an assisted decision-making tool and a follow-up tracking system for patients. The study is observational and does not involve any direct interventions.

Why it matters

Potential benefit: If successful, this system could significantly improve the diagnosis and management of childhood brain diseases, leading to better patient outcomes.

How similar studies have gone: While this approach is innovative, similar studies utilizing technology for diagnosis and treatment in pediatric populations have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited;

Exclusion Criteria:

* 1\. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors;
* 2\. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease);

Where it's running

  • Jiangsu Provincial Hospital of Traditional Chinese Medicine
    Nanjing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.